VistaGen Therapeutics (VTGN)

• Market cap: $125M
• 1 day: -2.16%
• 5 days: -1.69%
• 1 month: 17.29%
• 3 months: 50.18%
• 6 months: 73.93%
• Year to date: 22.59%
• 1 year: 34.32%
• 5 years: -80.89%
• 10 years: -96.7%
• Sector: Healthcare
• Industry: Biotechnology

About: Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.

Employees: 57